explore -WSS

explore

author：comprehensive 2025-10-01 12:11:53 - browse：991

Photo illustration of three children against a blue background. -- health coverage from STAT — The Pashai children (from left): Abubakar, Mohammad, and Sufyan. Illustration: STAT; Photo Courtesy

On a sweltering day in August 2021, as the engines of a hulking C-17 cargo plane drowned out pops of gunfire and Taliban rocket explosions around them, the young Afghan couple looked down at their 4-month-old son, Mohammad, and felt a shuddering wave of relief. But as the plane lifted above the dusty peaks that hug Kabul like a fortress of sandstone and schist, that feeling grew heavy with grief — for the parents and siblings they were leaving behind, and for Afghanistan, the only home they’d ever known. They did not know when, if ever, they would set foot there again.

Three years later, the Pashais are fearing for their family’s lives once again. This time the existential threat they face isn’t war, but a pair of faulty genes, silently passed down through their families for generations before detonating on American soil.

In October, Mohammad was diagnosed with a rare inherited disorder — metachromatic leukodystrophy. Genetic tests revealed his youngest brother, Sufyan, though he’s showing no symptoms, also has the disease. There’s a potential cure for Sufyan, a company offering it free of charge, and a team of doctors in Minnesota ready to administer it. But the Medicaid program in the Pashais’ new home state of Texas has said it won’t cover the cost of even an initial consult to confirm he’s a good candidate for the treatment.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study

WSS

President Biden's budget: Here's what you might have missed

Doctors have an ethical obligation to be advocates

Sophia Smith scores twice for US in in 3

EPA limits use of carcinogenic gas for sterilizing medical devices

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

Why scientists need input from humanists on sensitive research

leisure time

explore

focus

Malaria cases in Florida and Texas: Here’s what you need to know

Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline

Bright Health sells Medicare Advantage business to Molina

Mike Pence ‘not interested in trading insults’ with Trump as he tries to win New Hampshire

The high cost of giving birth even with insurance

HHS secretary Becerra pressed on Change HealthCare cyberattack

BioMarin wins approval for gene therapy to treat hemophilia A

Inside the culture of fear in the White House science office of Eric Lander

Medicare proposal to cover medical devices draws a mixed reaction

President Biden's budget: Here's what you might have missed

hotspot

Severe heat forecast: Where scorching temperatures will persist over the next week

As AI in medicine takes off, can 'human in the loop' prevent harm?

President Biden's budget: Here's what you might have missed

UCLA team creates talking throat patch for voice disorders

Readout Newsletter: CAR

Novartis develops a rapidly manufactured CAR

focus

explore

focus

entertainment